Equities / Sectors / Healthcare
Healthcare
#5 by market capPharmaceuticals, biotechnology, medical devices and care providers. 565 US-listed equities across 10 industries; the sector accounts for 9.4% of tracked equity market cap and 9% of daily volume.
Market cap
$7.678T
-1.39%
-$107.296B · 1D
Sector weight
9.4%
of tracked market cap
Volume 24h
$59.692B
9% of market volume
Revenue TTM
$4.184T
Sum of constituents
Net income TTM
$152.8B
3.7% net margin
P/E (TTM)
50×
Market 30.1×
Dividend yield
1.8%
Market 1.4%
Employees
4.4M
Across 565 companies
Industry breakdown
Share of sector market cap · 10 industries
Concentration
Share of sector market cap by constituent
HHI index
388.7
Mega caps
7
Median cap
$1.412B
Valuation vs. market
Sector totals valued as one company; marker is the all-equities median
Trading at a 66% P/E premium to the all-equities market.
Returns vs. market
Cap-weighted price return · spread in percentage points
| Period | Sector | Market | Spread |
|---|---|---|---|
| 1 day | -1.39% | +0.11% | -1.50% |
| 1 week | -2.10% | -0.71% | -1.39% |
| 1 month | -2.93% | +0.10% | -3.02% |
| 3 months | +0.64% | +0.91% | -0.27% |
| Year to date | +8.41% | +11.07% | -2.66% |
| 1 year | +17.83% | +12.50% | +5.33% |
Constituents
565 equities · sorted by market cap
| # | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly and Company LLY · US | Drug Manufacturers - General | $1.025T | 13.4% | $1.15K | -0.62% | -2.71% | -0.88% | $2.498B | 38.4× |
| 2 | Johnson & Johnson JNJ · US | Drug Manufacturers - General | $622.912B | 8.1% | $258.66 | -2.30% | -4.44% | -4.62% | $2.144B | 29.6× |
| 3 | AbbVie Inc. ABBV · US | Drug Manufacturers - General | $459.314B | 6% | $259.93 | -0.63% | -1.96% | -0.02% | $1.011B | 73.3× |
| 4 | Merck & Co., Inc. MRK · US | Drug Manufacturers - General | $355.167B | 4.6% | $143.81 | -1.03% | -2.82% | -4.04% | $1.13B | 39.8× |
| 5 | UnitedHealth Group Inc. UNH · US | Healthcare Plans | $330.506B | 4.3% | $365.20 | -0.51% | -2.62% | -7.85% | $1.439B | 23.4× |
| 6 | Thermo Fisher Scientific Inc. TMO · US | Diagnostics & Research | $242.487B | 3.2% | $652.51 | -3.34% | -3.82% | +8.66% | $1.55B | 35.4× |
| 7 | Amgen Inc. Common Stock AMGN · US | Drug Manufacturers - General | $220.17B | 2.9% | $407.27 | -3.38% | +0.30% | -7.04% | $1.018B | 25.2× |
| 8 | Gilead Sciences, Inc. GILD · US | Drug Manufacturers - General | $183.048B | 2.4% | $147.50 | -1.04% | -1.46% | -1.61% | $654.68M | -56.5× |
| 9 | Abbott Laboratories ABT · US | Medical Devices | $168.416B | 2.2% | $96.69 | -2.17% | -4.33% | -11.24% | $856.86M | 26.8× |
| 10 | Pfizer Inc. PFE · US | Drug Manufacturers - General | $160.256B | 2.1% | $28.12 | -1.40% | -1.02% | -1.51% | $857.08M | 21.4× |
| 11 | Danaher Corp. DHR · US | Diagnostics & Research | $148.846B | 1.9% | $211.76 | -4.42% | -5.37% | +2.33% | $1.123B | 37.2× |
| 12 | Intuitive Surgical Inc. ISRG · US | Medical Instruments & Supplies | $141.999B | 1.8% | $401.24 | -1.33% | +0.43% | +8.66% | $606.39M | 45.2× |
| 13 | Biotechnology | $128.381B | 1.7% | $506.74 | -3.07% | -2.99% | -7.47% | $605.25M | 29.1× | |
| 14 | Bristol-Myers Squibb Company BMY · US | Drug Manufacturers - General | $125.485B | 1.6% | $61.46 | -1.51% | -0.07% | -8.16% | $661.81M | 13.5× |
| 15 | Medtronic plc MDT · US | Medical Devices | $110.647B | 1.4% | $86.44 | +0.17% | -2.34% | -6.08% | $2.531B | 21.2× |
| 16 | CVS Health Corporation Common Stock CVS · US | Healthcare Plans | $108.886B | 1.4% | $85.20 | -0.57% | +0.18% | -12.70% | $558.92M | 22.3× |
| 17 | McKesson Corporation MCK · US | Medical Distribution | $107.858B | 1.4% | $898.82 | +5.27% | +3.39% | -0.88% | $1.088B | 22.7× |
| 18 | Stryker Corp. SYK · US | Medical Devices | $104.7B | 1.4% | $272.96 | -0.88% | +1.19% | -14.00% | $672.55M | 28.1× |
| 19 | HCA Healthcare, Inc. HCA · US | Medical Care Facilities | $92.283B | 1.2% | $423.39 | -0.79% | -0.02% | +2.37% | $465.26M | 13.5× |
| 20 | Elevance Health, Inc. ELV · US | Healthcare Plans | $82.963B | 1.1% | $381.67 | -1.84% | -4.16% | -5.30% | $452.97M | 15.8× |
| 21 | Regeneron Pharmaceuticals, Inc. REGN · US | Biotechnology | $77.168B | 1% | $734.81 | -3.09% | -7.69% | -10.80% | $766.26M | 17.5× |
| 22 | Moderna Inc. MRNA · US | Biotechnology | $75.387B | 1% | $188.94 | -1.89% | -3.02% | +22.47% | $2.913B | -23.9× |
| 23 | The Cigna Group CI · US | Healthcare Plans | $70.643B | 0.9% | $267.96 | -1.42% | +0.93% | -5.34% | $530.83M | 11× |
| 24 | Boston Scientific Corp. BSX · US | Medical Devices | $62.541B | 0.8% | $43.23 | -0.96% | -3.25% | -10.09% | $775.19M | 17× |
| 25 | Cencora Inc. COR · US | Medical Distribution | $59.114B | 0.8% | $309.78 | +3.17% | -0.03% | -6.40% | $585.36M | 22.5× |